levodopa has been researched along with benzofurans in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brotchie, JM; Crossman, AR; Hill, MP; Hughes, NR; McKnight, AT; Woodruff, GN | 1 |
Knoll, J; Shimazu, S; Tamashiro, A; Yoneda, F | 1 |
Kubo, I; Nihei, K; Shimizu, K | 1 |
Enokizono, J; Hagihara, K; Iida, K; Kashima, H; Kurokawa, M; Nonaka, H; Shimada, J; Uchida, S | 1 |
di Marzo, V; Freestone, PS; Guatteo, E; Lipski, J; Mercuri, NB; Piscitelli, F | 1 |
Cao, L; Hao, H; Hao, K; Li, F; Liu, H; Qi, Q; Wang, H | 1 |
De Deurwaerdère, P; Di Giovanni, G; Navailles, S | 1 |
7 other study(ies) available for levodopa and benzofurans
Article | Year |
---|---|
Kappa-opioid receptor agonists increase locomotor activity in the monoamine-depleted rat model of parkinsonism.
Topics: alpha-Methyltyrosine; Animals; Antiparkinson Agents; Benzeneacetamides; Benzofurans; Dose-Response Relationship, Drug; Drug Synergism; Levodopa; Male; Motor Activity; Parkinson Disease, Secondary; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Reserpine | 1998 |
The L-DOPA-sparing effect of R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane hydrochloride [(-)-BPAP] in reserpine-pretreated rats.
Topics: alpha-Methyltyrosine; Animals; Benzofurans; Drug Synergism; Levodopa; Male; Motor Activity; Rats; Rats, Wistar; Reserpine | 2003 |
Oxidation products of quercetin catalyzed by mushroom tyrosinase.
Topics: Agaricales; Benzofurans; Chromatography, High Pressure Liquid; Levodopa; Monophenol Monooxygenase; Oxidation-Reduction; Polarography; Quercetin; Quinones | 2004 |
Novel 4-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)methylbenzofuran derivatives as selective alpha(2C)-adrenergic receptor antagonists.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Benzofurans; Callithrix; Dopamine Agents; Dyskinesia, Drug-Induced; Humans; Indicators and Reagents; Isoquinolines; Levodopa; Receptors, Adrenergic, alpha-2; Structure-Activity Relationship | 2007 |
Glutamate spillover drives endocannabinoid production and inhibits GABAergic transmission in the Substantia Nigra pars compacta.
Topics: Animals; Arachidonic Acids; Benzofurans; Calcium; Cannabinoid Receptor Antagonists; Central Nervous System Agents; Dopamine; Dopamine Agents; Dopaminergic Neurons; Endocannabinoids; Glutamic Acid; Guanosine Diphosphate; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Levodopa; Neurons; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptors, Metabotropic Glutamate; Rimonabant; Substantia Nigra; Synaptic Transmission; Thionucleotides | 2014 |
Salvianolic acid B as a substrate and weak catechol-O-methyltransferase inhibitor in rats.
Topics: Animals; Benzofurans; Benzophenones; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Dihydroxyphenylalanine; Kinetics; Levodopa; Male; Metabolome; Methylation; Nitrophenols; Organ Specificity; Rats, Sprague-Dawley; Reproducibility of Results; Substrate Specificity; Tolcapone; Tyrosine | 2015 |
The 5-HT4 Agonist Prucalopride Stimulates L-DOPA-Induced Dopamine Release in Restricted Brain Regions of the Hemiparkinsonian Rat In Vivo.
Topics: Animals; Benzofurans; Brain; Dopamine; Dopamine Agents; Functional Laterality; Indoles; Levodopa; Microdialysis; Oxidopamine; Parkinsonian Disorders; Rats; Serotonin 5-HT4 Receptor Agonists; Serotonin 5-HT4 Receptor Antagonists; Sulfonamides | 2015 |